Millie
your market intelligence analyst
Search Results
206 results
Your search is now limited to «Eli Lilly» expert search.
Due to the limited treatment options currently available for adult patients with AD, we're excited to further explore baricitinib's potential benefit for patients," said Patrik Jonsson, Lilly senior vice president and president of Lilly Bio-Medicines.
More from Healthcare Sales & Marketing Network:
Becker's Hospital Review 09/17/2020 15:36
Eli Lilly's chief scientific officer, Daniel Skovronsky, MD, PhD, said that based on clinical studies, he believes the antibody drugs could play an important role in the fight against COVID-19.
More from Becker's Hospital Review:
Seeking Alpha 09/17/2020 12:36
Its margin expansion profile represents one of the strongest in the pharma industry, with the potential for mid-teens EPS growth.
More from Seeking Alpha:
Investor's Business Daily 09/17/2020 09:29
Drug giants Eli Lilly (LLY) and Amgen (AMGN) on Thursday announced they are teaming up to boost supplies of Lilly's potential Covid-19 treatments.
More from Investor's Business Daily:
FiercePharmaManufacturing 09/17/2020 09:02
Eli Lilly believes so strongly in its contender that it's bringing on a major pharma partner to chip in on production.
More from FiercePharmaManufacturing:
Financial Post (Canada) 09/17/2020 08:13
Eli Lilly and Co on Thursday partnered with Amgen Inc to increase the supply of its experimental COVID-19 antibody treatments, a day after one of Lilly’s drugs was shown to reduce the need for hospitalization.
More from Financial Post (Canada):
CNBC - Business 09/17/2020 07:58
Eli Lilly on Wednesday reported that a single infusion of its experimental antibody treatment cut hospitalizations and emergency room visits for clinical trial patients with moderate Covid-19.
More from CNBC - Business:
Lilly Forward Looking Statements This press release contains forward-looking statements about the supply and use of Lilly antibodies to treat or prevent COVID-19 and reflects Lilly's current beliefs.
More from Eli Lilly and Company News Releases:
World Pharma News 09/17/2020 04:00
Lilly is currently studying several potential neutralizing antibodies for the prevention and/or treatment of COVID-19 as either monotherapy or in combination.
More from World Pharma News:

Therapeutic Areas

Clinical Trials and Phases

Business Issues

Companies - Public

Companies - Venture Funded

Financial Results

Global Markets

Global Risk Factors

Government Agencies

Job Titles

Legal and Regulatory

Cell Receptors

Cells

Diagnostics and Therapeutics

Diseases

Drugs - Brand Names

Drugs - Generic

Enzymes

Genes

Health Care

Health and Wellness

Human Anatomy

Mechanisms of Action

Medical Devices

Proteins

Sources

Strategic Scenarios

Trends

Hints:

On this page, you see the results of the search you have run.  You may also view the following:

  •  Click on this drop-down menu on the right hand side of the page, to choose between the machine learning-produced Insights Reports, or the listing of concepts extracted from the results, in chart or list format. 


  •  View the number of search results returned for the search in each of your collections, and click on any of those numbers to view the entire listing of results from the chosen collection.

  •  Use the search adjustment drop-downs to change the scope, sorting, and presentation of your results.

  •  Show or hide the record’s caption (content description).

  •  Show actions that can be made with the search result record.

  •  Click on the Save button after running your search, to save it so that its results will be updated each time relevant new content is added to the designated collection. You may choose to be notified via search alerts.

Click here for more info on Search Results

Click here for more info on Machine Learning applications